Skip to main content
. 2007 Jun 26;97(3):412–419. doi: 10.1038/sj.bjc.6603867

Table 1. The distribution of F-cells immunohistochemically detected in nephroblastoma.

        F-cells features
 
No. Gender Age (years) Clinical parameters BV PBV TC GL TB NK Staining grade
1 Female 6 Stage IV, pulmonary metastases, died Fer++ (−) Fer (−) (−)   (+++)
2 Female 7 Stage III, died Fer++ Fer Fer       (+++++)
3 Female 8 Stage III, died   Fer No Fc       (+++)
4 Male 5 Stage IV, pulmonary metastases, remission, relapse, remission Fer+ (−) No Fc (−) (−)   (+)
5 Male 4 Stage III, remission Fer++ (−) Fer,Feb (−) (−)   (+++++)
6 Male 8 Stage III, remission Fer++ (−)         (++)
7 Female 13 Stage III, remission Fer,Feb+   Fer,Feb Fer,Feb     (+++++)
8 Female 11 Stage III ,remission Fer++ Fer No Fc       (+++++)
9 Male 3 Stage III, relapse and remission (−) (−) No Fc Fer Fer   (++++)
10 Male 2 Stage III, remission, adjacent NK Fer+ (−) No Fc (−) Fer   <(+)
11–13 Females 4, 5, 9 Stage II, remission, adjacent NK No Fc   (−)
14 Male 2 Metastatic stage IV, lung with metastases. Chemother(+) (−) (−) Fer       (++++)
15 Male 6 Stage III+adjacent NK Fer+ (−) No Fc     No Fc (+++)
16 Female 1 Stage III+adjacent NK Fer+ (−) No Fc     No Fc (+++)
17 Male 1 Stage II Fer+   Feb (−) (−)   (+++++)
18 Male 7 Stage II (−) (−) Fer (−) (−)   (+++)
19 Female 2 Stage I Fer+ (−) Feb (−) (−)    
20 Female 3 Stage I Fer+ (−) Fer (−) (−)   (+++)
21 Male 1 Stage I Fer+ (−) Fer (−) (−)   (+++)
22 Female 4 Stage I+counterpart NK. Chemoth(+) (−) (−) Fer (−) (−) No Fc (+++)
23 Male 14/12 Stage I (−) (−) No Fc (−) Fer   (+++)
24 Female 1 Stage I adjacent NK. Chemoth(+) No Fc (−)
25–29 3 female 2 male 2, 3, 5 17, 22 Stage I (4), stage II (1) No Fc (−)
30–32 1 female 2 male 4, 7, 9 Kidney of glomerulonephritis No Fc (−)

Abbreviations: (−), tissue not present in the section; BV, normal blood vessels; Fc, F-cells; Feb, F-erythroblasts; Fer, F-erythrocytes; Fer+, low percent of FER; Fer++, high percent of Fer; GL, glomeruloid bodies; NK, normal kidney; PBV, proliferating blood vessels; TB, tubular structures; TC, undifferentiated tumour cells.